Biographical Sketch
Leann Olansky, MD, is a Staff Physician in the Department of Endocrinology, located on the main campus of Cleveland Clinic. She was appointed in 2006. Dr. Olansky is board-certified in the subspecialty of endocrinology by the American Board of Internal Medicine.
Dr. Olansky's particular interests include diabetes, diabetes complications and glucose sensing technology for management of diabetes.
Specialty Interests
Adrenal disorders, Androgen Excess, Diabetes, diabetes and diabetes complications, diabetes mellitus, endocrine complications of pregnancy, endocrine immunology, endocrinology, Flushing Syndromes, general endocrinology, growth hormone in adults, gynecomastia (breast enlargement), hair loss in women, Hirsutism, hirsutism thyroid disorder, hyperlipidemia, including pituitary and adrenal diseases, insulin resistance and cardiovascular risk prevention, Lipid Disorders, Menopause, metabolic bone and skeletal problems, Metabolic Syndrome, metabolism, multiple endocrine neoplasia syndromes, Obesity, Osteoporosis, osteoporosis and calcium metabolism, parathyroid and calcium disorders, thyroid, thyroid cancers, thyroid disease, thyroid disorders, thyroid nodules, type 1 diabetes
Awards & Honors
Elected to AOA, Emory University Chapter, 1975
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/9/2008, Dr.
Olansky has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Olansky receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Aymlin
Eli Lilly and Company
Merck & Co., Inc.
Sanofi-Aventis US Inc.
Takeda
